Copy-Number Variation

  • Copy-number variation (CNV) refers to a type of structural genetic variation in which sections of DNA are present in different numbers of copies among individuals of the same species. These variations may involve the deletion or duplication of DNA segments and can range from several hundred base pairs to millions of base pairs in length. Unlike single-nucleotide polymorphisms (SNPs), which involve changes in individual DNA bases, CNVs alter the quantity of genetic material within a genome. They are an important source of genetic diversity and can influence gene expression, biological development, disease susceptibility, adaptation, and evolutionary processes.
  • Copy-number variations commonly include deletions, duplications, and more complex rearrangements. A deletion reduces the number of copies of a genomic region, whereas a duplication increases its copy number. For example, an individual may carry one, two, three, or more copies of a particular gene, depending on the genomic region and the type of variation. A region with a higher or lower copy number than the reference genome may be classified as a copy-number variant. The term copy-number polymorphism is often used when a CNV is sufficiently common within a population. Although CNVs are frequently discussed as a distinct category of structural variation, they overlap with other structural variants, particularly large insertions and deletions.
  • CNVs arise through several molecular mechanisms. Non-allelic homologous recombination (NAHR) occurs when similar DNA sequences at different genomic locations mistakenly align during meiosis or DNA repair, resulting in deletions or duplications. Non-homologous end joining (NHEJ) repairs DNA double-strand breaks by joining broken DNA ends, sometimes producing deletions, duplications, or complex rearrangements. Replication-based mechanisms, including fork stalling and template switching (FoSTeS) and microhomology-mediated break-induced replication (MMBIR), can generate complex copy-number changes when DNA replication machinery switches between templates. Transposable elements and repetitive DNA sequences can also contribute to CNV formation by promoting recombination and genome rearrangements.
  • Copy-number variations can influence biological functions through several mechanisms. One important effect is gene dosage, which refers to the amount of a gene available in the genome. Increased gene copy number may lead to higher gene expression, although this relationship is not always linear because regulatory mechanisms can compensate for dosage changes. Conversely, gene deletions may reduce gene expression or eliminate gene function. CNVs can also disrupt coding sequences, alter gene structure, remove regulatory elements, or change the distance between genes and their promoters or enhancers. Some CNVs affect multiple genes simultaneously, producing broader effects on cellular processes and organismal characteristics.
  • The functional consequences of CNVs depend on their genomic location, size, gene content, copy number, and regulatory environment. A duplication involving a gene associated with metabolism may alter enzyme production, while a deletion affecting an immune-related gene may influence disease resistance. CNVs involving developmental genes can affect growth, morphology, fertility, and other biological characteristics. However, many CNVs occur in non-coding regions and may have little detectable effect, while others influence gene regulation through changes in enhancers, silencers, chromatin organization, or three-dimensional genome architecture.
  • CNVs are associated with several human genetic disorders and complex diseases. Certain deletions and duplications contribute to genomic disorders, including conditions caused by recurrent rearrangements in particular chromosomal regions. Gene amplification can also contribute to cancer development by increasing the copy number of oncogenes, while deletions may remove tumour-suppressor genes. CNVs can influence susceptibility to neurological, metabolic, immune-related, and infectious diseases. However, the presence of a CNV does not automatically indicate disease, because its effect may depend on the specific genes involved, the individual’s genetic background, environmental conditions, and other interacting factors.
  • In animal genetics and breeding, copy-number variation is an important source of genetic variation affecting economically important traits. CNVs have been investigated in cattle, sheep, goats, pigs, chickens, horses, and other livestock species. They may influence growth rate, body composition, feed efficiency, milk production, milk composition, meat quality, reproductive performance, disease resistance, and environmental adaptation. For example, variation in the copy number of genes involved in digestive processes, metabolism, immune function, and development may contribute to differences in production and adaptation among animals. CNVs may also affect fertility, embryonic development, and genetic disorders in breeding populations.
  • The detection of CNVs requires specialized genomic technologies because their size and structure can make them difficult to identify using conventional SNP-based approaches. Comparative genomic hybridization (CGH) arrays and SNP genotyping arrays are widely used for detecting copy-number changes across the genome. Array comparative genomic hybridization (aCGH) compares DNA from a test sample with reference DNA to identify regions of increased or decreased copy number. SNP arrays estimate copy number using signal intensity and additional information from allelic patterns. Although these technologies can detect many CNVs, their resolution depends on probe density and genomic coverage.
  • Next-generation sequencing (NGS) provides more detailed opportunities for CNV detection. Whole-genome sequencing (WGS) can identify copy-number changes through read-depth analysis, in which the number of sequencing reads aligned to a genomic region is compared with expected coverage. Paired-end sequencing can identify abnormal distances or orientations between paired reads, while split-read analysis detects reads spanning structural-variation breakpoints. These approaches can provide complementary evidence for CNV identification. Whole-exome sequencing (WES) can detect copy-number changes affecting captured coding regions, although its ability to identify CNVs in non-coding regions is limited.
  • Long-read sequencing technologies, including Oxford Nanopore and Pacific Biosciences (PacBio), provide additional advantages for characterizing complex CNVs. Long sequencing reads can span repetitive regions and structural-variation breakpoints, helping to resolve genomic regions that are difficult to analyse using short reads. Optical genome mapping provides another approach for detecting large structural variations by analysing labelled DNA molecules and their physical patterns. Combining short-read sequencing, long-read sequencing, and optical mapping can improve the accuracy and completeness of CNV characterization.
  • Bioinformatics analysis plays a central role in CNV detection, validation, and interpretation. Raw sequencing data are initially assessed using tools such as FastQC and MultiQC, followed by adapter trimming and quality filtering with programs such as fastp or Cutadapt. Reads are aligned to a reference genome using tools such as BWA, Bowtie2, or minimap2, depending on the sequencing technology. CNV detection can then be performed using read-depth tools such as CNVnator and Control-FREEC, or structural-variation callers such as Manta, DELLY, LUMPY, and GRIDSS. Long-read CNV and structural-variation detection can use tools such as Sniffles, cuteSV, and pbsv. Different tools identify different types of evidence, so combining multiple approaches can improve detection reliability.
  • After identification, CNVs are characterized according to their genomic coordinates, size, type, copy number, and affected genes. Annotation tools and resources such as Ensembl, AnnotSV, ClinVar, the Database of Genomic Variants (DGV), and gnomAD structural-variation resources can help interpret their genomic and potential functional significance. Researchers may also investigate whether CNVs overlap with genes, promoters, enhancers, regulatory elements, quantitative trait loci (QTLs), or genome-wide association study (GWAS) signals. Integrating CNV data with RNA sequencing (RNA-seq), gene-expression profiles, DNA methylation, chromatin accessibility, and other omics datasets can provide further insight into their biological effects.
  • Statistical analysis is important for investigating associations between CNVs and phenotypic traits. Researchers may compare CNV frequencies and copy-number states between populations or individuals with different phenotypes. Association studies can identify CNVs linked to disease susceptibility, production performance, fertility, growth, or other characteristics. However, population structure, relatedness, batch effects, sequencing coverage, and technical errors must be considered to avoid false associations. CNV validation using quantitative PCR (qPCR), digital droplet PCR (ddPCR), fluorescence in situ hybridization (FISH), or independent sequencing approaches can help confirm candidate variants.
  • Copy-number variation is also important in evolutionary and population genomics. CNVs can contribute to adaptation by changing the dosage of genes involved in environmental responses, metabolism, immunity, and development. Differences in CNV frequencies among populations may reflect natural selection, genetic drift, migration, and population history. Gene duplications can provide opportunities for functional diversification, allowing duplicated genes to acquire new functions or specialize in existing biological processes. Consequently, CNVs contribute to genome evolution and the genetic diversity of populations.
  • Despite their importance, accurate CNV detection remains challenging. Repetitive DNA, segmental duplications, complex genomic regions, sequencing errors, and variable read coverage can lead to false-positive or false-negative results. Different analytical methods may produce different CNV boundaries and copy-number estimates. Reference-genome limitations can also affect detection, particularly in species with incomplete or poorly annotated genomes. In addition, distinguishing benign CNVs from variants with functional or harmful effects requires reliable population references, functional annotation, statistical evidence, and experimental validation.
  • In modern bioinformatics, copy-number variation analysis is an essential component of structural-variant detection, genome annotation, functional genomics, disease research, and evolutionary studies. Its integration with SNP analysis, genome-wide association studies, quantitative trait loci, transcriptomics, epigenomics, and genomic selection can improve understanding of the genetic architecture of complex traits. In animal breeding, identifying beneficial CNVs and understanding their effects may support more accurate genetic evaluation, improved selection decisions, and the development of livestock populations with better productivity, health, fertility, and environmental adaptation.
Author:

Leave a Reply

Your email address will not be published. Required fields are marked *